Insulin therapy for newly-diagnosed diabetics Feb. 17, 2011 Article: A randomized, controlled trial comparing twice-a-day insulin glargine mixed with rapid-acting insulin analogs versus standard neutral protamine Hagedorn (NPH) therapy in newly diagnosed type 1 diabetes. Reviewer: Dr. Heidi Erickson